Performance of confirmatory interferon-γ release assays in school TB outbreaks

Chest

Volumn 141, Issue 4, 2012, Pages 983-988

  Song, Seunghwan ^a   Jeon, Doosoo ^a   Kim, Jong Won ^a   Kim, Yeong Dae ^a   Kim, Sang Pil ^a   Cho, Jeong Su ^a   Lee, Seung Eun ^a   Cho, Woo Hyun ^a   Park, Hye Kyung ^a   Kim, Yun Seong ^a   Lee, Min Ki ^a   Lee, Jun Ho ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CONTACT EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; EPIDEMIC; FEMALE; FOLLOW UP; GOLD STANDARD; HIGH SCHOOL STUDENT; HUMAN; INCIDENCE; INFECTION RATE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOUTH KOREA; TUBERCULIN TEST;

EID: 84859494251     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1158     Document Type: Article

References (21)

1. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med. 2001;163(4):824-828. (Pubitemid 32275850)
2. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177-184.
3. Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009;33(5):956-973.
4. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest. 2010;137(4):952-968.
5. Lalvani A, Pareek M. A 100 year update on diagnosis of tuberculosis infection. Br Med Bull. 2010;93:69-84.
6. National Institute for Health and Clinical Excellence (NICE). Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. London, England: NICE; 2006.
7. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010;59(RR-5):1-25.
8. Amicosante M, Ciccozzi M, Markova R. Rational use of immunodiagnostic tools for tuberculosis infection: Guidelines and cost effectiveness studies. New Microbiol. 2010;33(2):93-107.
9. Korean Centers for Disease Control and Prevention. Control of Tuberculosis in Korea 2009. Seoul, Korea: Korean CDC; 2009.
10. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med. 2011;183(1):88-95.
11. Leung CC, Yam WC, Yew WW, et al. T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med. 2010;182(6):834-840.
12. Kik SV, Franken WP, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J. 2010;35(6):1346-1353.
13. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008;177(10):1164-1170. (Pubitemid 351717577)
14. Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med. 2008;149(11):777-787.
15. Lienhardt C, Fielding K, Hane AA, et al. Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS ONE. 2010;5(5):e10508.
16. Hill PC, Jackson-Sillah DJ, Fox A, et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE. 2008;3(1):e1379.
17. Korean Centers for Disease Control and Prevention. Annual Report on the Notified Tuberculosis Patients in Korea 2009. Seoul, Korea: Korean CDC; 2010.
18. Kang YA, Lee HW, Yoon HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005;293(22):2756-2761.
19. Jong Lee K, Ae Kang Y, Mi Kim Y, et al. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay. Scand J Infect Dis. 2010;42(9):672-678.
20. Kim EY, Lim JE, Jung JY, et al. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis. 2009;9:207.
21. van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE. 2009;4(12):e8517